Tumor-Targeted Oxaliplatin(IV) Prodrug Delivery Based on ROS-Regulated Cancer-Selective Glycan Labeling-Reference-Cited by-同舟云学术

Tumor-Targeted Oxaliplatin(IV) Prodrug Delivery Based on ROS-Regulated Cancer-Selective Glycan Labeling

Published:2024-05-13 Issue:10 Volume:67 Page:8296-8308
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Wang Jiajia¹^ORCID,Cao Wei¹,Zhang Wei²,Dou Biao¹,Ding Xin¹,Wang Menghe¹,Ma Jing²,Li Xia¹

Affiliation:

1. Joint National Laboratory for Antibody Drug Engineering, The First Affiliated Hospital of Henan University, Henan University, Kaifeng 475000, China

2. School of Pharmacy, Institute for Innovative Drug Design and Evaluation, Henan University, Kaifeng 475000, China

Funder

National Natural Science Foundation of China

Project of Innovation and Entrepreneurship Support Program for College Students of Henan University

Postdoctoral Research Grant in Henan Province

Key Research and Development and Promotion Special Project in Henan Province

Joint Construction Project of Henan Medical Science and Technology Project

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c00459

Reference26 articles.

1. Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action

2. Platinum-based drugs for cancer therapy and anti-tumor strategies

3. Impact of platinum-based chemotherapy on the prognosis of early triple-negative breast cancer: a systematic review and meta-analysis

4. Metabolic glycoengineering – exploring glycosylation with bioorthogonal chemistry

5. Targeting HER2-positive breast cancer: advances and future directions

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of relationships between metabolic chemical reporter structures and S-glyco-modification effects;Bioorganic Chemistry;2024-10

2. Ultrasound-activated mechanochemical reactions for controllable biomedical applications;Smart Materials in Medicine;2024-09

3. A hydroxychloroquine platinum(iv) conjugate displaying potent antimetastatic activities by suppressing autophagy to improve the tumor microenvironment;Dalton Transactions;2024